In vitro diagnostic products are those reagents, instruments, and systems intended for use in diagnosis of disease or other conditions, including a determination of the state of health, in order to cure, mitigate, treat, or prevent disease or its sequelae. In-Vitro Diagnostics (IVD) includes IVD Instrument Kits and Other Kits on the base of classification, which represent 91% and 9% of global In-Vitro diagnostics (IVD) market.
Diabetes, Cancer and Autoimmune Diseases are the main application of In-Vitro diagnostics (IVD) product and North American is the largest In-Vitro diagnostics (IVD) market on production and consumption.
Global In-Vitro diagnostics (IVD) market is projected to reach $ 72.54 Billion by 2019, with a GAGR of 7.8% from 2015, and Asia will have a big dynamic momentum on the market growth. The major players in the global In-Vitro diagnostics (IVD) market are KHB, SYSMEX, Abbott, Danaher, Roche, Siemens, Biomerieux etc..
Ad Statistics
Times Displayed: 7647
Times Visited: 24 Brand-New FDA-cleared Advanced Ultrasound Medical Device available for sale or lease to Wound Care Centers or any other Medical Facilities.The Arobella 1000D is designed for non-contact or debridement ultrasound wound healing therapy, or any other wounds
Read Full Report: http://www.gosreports.com/global-in-vitro-diagnostics-ivd-report/
Joanna | Executive – International Business and partner Relations
E-mail: info@gosreports.com | Tel: 1-510-400-8520
Web: www.gosreports.com
